All Reports Events Blogs Videos
Showing 333 results
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Roundtable
    April 16, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Thursday, May 07, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Roundtable
    March 31, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Tuesday, April 14, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Viewpoint
    March 25, 2026

    Life sciences enterprises are operating in a market access environment defined by pricing reforms, heightened transparency, and evolving health technology assessment expectations. Market access now begins well before regulatory approvals, requiring early evidence alignment, global-local coordination,…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • See Us At
    Feb. 16, 2026

    Join Chunky Satija, Partner at Everest Group, for an exclusive in-person event focused on shaping the future of global market access amid regulatory change, featuring expert-led sessions, certifications, high-value networking, and celebrations of industry innovation. Register…
  • Video
    Feb. 03, 2026

    As Veeva becomes the cornerstone of strategic transformation in life sciences, expectations from service providers are rapidly evolving. In this Q&A session, Chunky Satija, Vice President, and Rohit K, Practice Director, from Everest Group, discuss the…
  • Innovation Watch
    Jan. 08, 2026

    AI has emerged as a transformative force in clinical development, by enhancing decision-making, automating manual processes, and improving trial execution across the value chain. This report explores generative, agentic, and advanced AI’s growing influence in the…
  • Voice of the Customer
    Dec. 18, 2025

    AI- and automation-enabled workflows, advanced data and analytics capabilities, and increasingly interoperable technology stacks are rapidly and meaningfully transforming the pharma platforms landscape. Together, these shifts are enabling greater efficiency, scalability, and agility across the biopharma…
  • Provider Compendium
    Dec. 17, 2025

    Life sciences organizations are increasingly prioritizing automation, configurability, and real-time visibility to support modern clinical trial requirements. As adaptive designs, decentralized models, and global multi-protocol studies become more prevalent, the role of Randomization and Trial Supply…
  • Provider Compendium
    Nov. 25, 2025

    Life sciences enterprises are accelerating their shift to modern digital platforms to meet evolving demands for agility, patient-centricity, and regulatory compliance. Traditional ERP and CRM systems are giving way to cloud-based platforms that enable intelligent, connected…
  • PEAK Matrix®
    Nov. 25, 2025

    With global and adaptive clinical trials’ rising complexities, life sciences organizations are increasingly adopting intelligent Randomization and Trial Supply Management (RTSM) platforms to enhance operational efficiency, ensure regulatory compliance, and safeguard patient integrity. RTSM systems have…
  • Provider Compendium
    Nov. 25, 2025

    Life sciences enterprises are accelerating their shift to modern digital platforms to meet evolving demands for agility, patient-centricity, and regulatory compliance. Traditional ERP and CRM systems are giving way to cloud-based platforms that enable intelligent, connected…
  • Provider Compendium
    Nov. 19, 2025

    Veeva has become a cornerstone in life sciences digital transformation, offering cloud-based platforms across clinical, regulatory, safety, quality, and commercial functions. As enterprises increasingly adopt Veeva’s vault-based applications and scale global deployments, the demand for specialized…
  • Blog
    Nov. 05, 2025

    In 2006, I visited my first captive center in Bengaluru. At the time, the model was still in its formative years – many multinational organizations were only beginning to explore the potential of setting up their own in-house centers…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Viewpoint
    Sep. 26, 2025

    MedTech organizations are under increasing pressure to reimagine stakeholder engagement in response to increasing demand for personalized, connected experiences across the entire device life cycle. Functional silos, disparate technologies, and a lack of cross-functional alignment constrain…
  • Viewpoint
    Sep. 24, 2025

    Pharma organizations today face increasing complexities in delivering cohesive engagement to diverse stakeholders such as healthcare professionals, key opinion leaders, patients, and payers. The current model, built on fragmented platforms and siloed workflows, struggles to support…

Items per page